Table 2.

Benchmarking of device-associated healthcare-acquired infection rates in our ICU (2008 and current reports) against the reports of International Nosocomial Infection Control Consortium (INICC) in a medical/surgical ICU

DUR/DA-HAI rate	INICCa (2007–2012)	Leblebicioglu et al.b (2003–2012)	Aly et al.c (2004–2005)	This reportd (2018–2019)
CL, DUR/	0.54 (0.54–0.54)	0.65 (0.65–0.65)	0.88	0.80 (0.8–0.84)
CLABSI rate	4.9 (4.8–5.1)	8.5 (8.0–9.1)	5.5	6.70 (4.7–8.8)
MV, DUR/	0.36 (0.36–0.36)	0.54 (0.54–0.54)	0.78	0.98 (0.97–0.99)
VAP rate	16.5 (16.1–16.8)	22.3 (21.3–23.2)	9.1	2.10 (0.94–3.2)
UC, DUR/	0.62 (0.62–0.62)	0.88 (0.88–0.88)	0.95	0.73 (0.71–0.76)
CAUTI rate	5.3 (5.2–5.8)	7.9 (7.5–8.4)	2.3	4.30 (2.8–5.7)

^aWorldwide report [41].

^bReport from Turkey as part of the INICC [36].

^c2008 report from our ICU [25].

^dPooled mean and 95% confidence intervals.